Best management of locally advanced inoperable breast cancer
نویسندگان
چکیده
1359-6349/$ see front matter Copyright 2013 ECCO – the European CanCer Organisation. All rights reserved. http://dx.doi.org/10.1016/j.ejcsup.2013.07.052 * Corresponding author: Tel.: +39 02 57489788; fax: +39 02 57489581. E-mail address: [email protected] (G. Curigliano). Giuseppe Curigliano *, Carmen Criscitiello, Angela Esposito, Luca Fumagalli, Lucia Gelao, Marzia Locatelli, Ida Minchella, Aron Goldhirsch
منابع مشابه
Chemotherapy and Management of Locally Advanced Carcinoma Cervix
Background & Objective:the present study was undertaken to ascertain the incidence of early, advanced cancer cervix and its recurrence and role of chemotherapy in locally advanced cancer cervix. Material and Methods: The present study was conducted in the Departments of Obstetrics & Gynaecology, Pathology and Radiotherapy and the specimens examined in the Department of Pathol...
متن کاملManagement of Locally Advanced Breast Cancer
In 1962, Bloom and colleagues described the natural history of locally advanced breast cancer.[1] (For the purposes of this manuscript, we will define locally advamced breast cancer as tumors that measure more than 5 cm, tumors that extend to the chest wall or skin, and tumors with fixed ipsilateral nodes or ipsilateral internal mammary nodes. These characteristics therefore correspond to opera...
متن کاملNeoadjuvant Chemotherapy Creates Surgery Opportunities For Inoperable Locally Advanced Breast Cancer
Neoadjuvant chemotherapy (NAC), the systematic chemotherapy given to patients with locally advanced and inoperable breast caner, has been proven to be of great clinical values. Many scientific reports confirmed NAC could effectively eliminate sub-clinical disseminated lesions of tumor, and improve long-term and disease-free survival rate of patients with locally advanced breast cancer (LABC); h...
متن کاملManagement of locally advanced breast cancer: evolution and current practice.
Locally advanced breast cancer (LABC) accounts for a sizeable number (30-60%) of breast cancer cases and is a common clinical scenario in developing countries. The treatment of LABC has evolved from single modality treatment, consisting of radical mutilating surgery or higher doses of radiotherapy in inoperable disease to multimodality management, which along with the above two included systemi...
متن کاملEvidence-based use of neoadjuvant taxane in operable and inoperable breast cancer.
Neoadjuvant chemotherapy (NC) is standard therapy for patients with locally advanced breast cancer and is increasingly used for early-stage operable disease. The aim of NC is a pathological complete response (pCR) in the breast and axillary lymph nodes, which is the best predictor of improved outcome and prolonged survival. The taxanes docetaxel and paclitaxel are potent agents in breast cancer...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 11 شماره
صفحات -
تاریخ انتشار 2013